HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.13
−8.86%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.1x
Market Cap
$6.19M
MomentumView details →
1D Return
−8.86%
YTD Return
−84.52%
RSI (14)
21.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.1x
Market Cap
$6.19M
RSI (14)
21.1
MomentumView details →
1D Return
−8.86%
YTD Return
−84.52%
SummaryUpdated Mar 1, 2026
Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) is a recently public company that went public on January 15, 2025. Founded by Lap Sun Wong on August 17, 2023, and headquartered in Hong Kong, the company operates in the specialized niche of pharmaceutical cross-border e-commerce supply chain services. Despite being a relatively new entity, the company has established itself as a facilitator of international pharmaceutical trade, particularly focusing on over-the-counter (OTC) medications and cross-border logistics solutions.
Similar companies
Latest newsMore news →
No recent news for HKPD.